{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:15:40Z","timestamp":1789193740918,"version":"build-2803163510"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Guillain\u2013Barr\u00e9 syndrome (GBS) is an autoimmune disease associated with significant morbidity. A wide variety of infectious and non-infectious triggers have been identified to be associated with GBS. COVID-19 has gained attention in recent years for its role in GBS pathogenesis. Our study aims to review the literature on GBS and its epidemiological and pathophysiological association with COVID-19.<\/jats:p><\/jats:sec><jats:sec><jats:title>Description<\/jats:title><jats:p>Recent literature on GBS associated with COVID-19 infections, such as case reports, case series, systematic reviews, and large-scale epidemiological studies, were reviewed. We also reviewed studies that included vaccines against COVID-19 in association with GBS. Studies that focused on understanding the pathobiology of GBS and its association with infectious agents including COVID-19 were reviewed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Despite a lack of consensus, GBS is strongly associated with COVID-19 infection. The exact pathophysiological mechanism regarding COVID-19 as a causative agent of GBS is unknown. Mechanisms, such as the proinflammatory state, triggering of autoimmunity, and direct viral invasion, are postulated and remain to be investigated. Adenovirus vector vaccines are most likely associated with GBS, and the consensual reports clearly suggest mRNA vaccines are associated with low risk and may be protective against GBS by reducing the risk of COVID-19 infection.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1396642","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T08:26:10Z","timestamp":1717575970000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Guillain\u2013Barre syndrome and link with COVID-19 infection and vaccination: a review of literature"],"prefix":"10.3389","volume":"15","author":[{"given":"Vijaya Lakshmi","family":"Valaparla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schweta P.","family":"Rane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chilvana","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.it.2022.02.003","article-title":"Guillain-Barr\u00e9 syndrome: expanding the concept of molecular mimicry","volume":"43","author":"Laman","year":"2022","journal-title":"Trends Immunol."},{"key":"B2","first-page":"24","article-title":"On a radiculoneuritis syndrome with hyperalbuminosis of cerebrospinal fluid without cellular reaction. Remarks on clinical and graphical character of tendon reflexes","volume":"150","author":"Guillain","year":"1999","journal-title":"Ann Med Interne (Paris)."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1111\/ene.14860","article-title":"Prevalence, clinical characteristics and outcomes of Guillain\u2013 Barr\u00e9 syndrome spectrum associated with COVID-19: a systematic review and meta-analysis","volume":"28","author":"Palaiodimou","year":"2021","journal-title":"Eur J Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s00415-020-10005-3","article-title":"Guillain\u2013Barr\u00e9 syndrome in the COVID-19 era: another occasional cluster?","volume":"268","author":"Tatu","year":"2021","journal-title":"J Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1136\/jnnp-2020-324837","article-title":"Guillain-Barr\u00e9 syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions","volume":"92","author":"Filosto","year":"2021","journal-title":"J Neurol Neurosurg Psychiatr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/ana.410090704","article-title":"Pathology of the Guillain-Barr\u00e9 syndrome","volume":"9","author":"Prineas","year":"1981","journal-title":"Annal Neurol Off J Am Neurol Assoc Child Neurology Soc."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1084\/jem.178.5.1771","article-title":"bacterium lipopolysaccharide that elicits Guillain-Barr\u00e9 syndrome has a GM1 ganglioside-like structure","volume":"178","author":"Yuki","year":"1993","journal-title":"J Exp Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/jnnp.2007.123943","article-title":"Immune responses to myelin proteins in Guillain\u2013Barr\u00e9 syndrome","volume":"79","author":"Makowska","year":"2008","journal-title":"J Neurol Neurosurg Psychiatr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ana.410310619","article-title":"Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome","volume":"31","author":"Chiba","year":"1992","journal-title":"Annal Neurol Off J Am Neurol Assoc t Child Neurol Soc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1212\/WNL.54.7.1453","article-title":"Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain\u2013Barr\u00e9 syndrome","volume":"54","author":"Ang","year":"2000","journal-title":"Neurology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"674922","DOI":"10.3389\/fimmu.2021.674922","article-title":"SARS-CoV-2 infection and Guillain-Barr\u00e9 syndrome: a review on potential pathogenic mechanisms","volume":"12","author":"Shoraka","year":"2021","journal-title":"Front Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-017-1001-8","article-title":"Meyer zu Horste G. Novel pathomechanisms in inflammatory neuropathies","volume":"14","author":"Schafflick","year":"2017","journal-title":"J Neuroinflam."},{"key":"B14","doi-asserted-by":"publisher","first-page":"588290","DOI":"10.3389\/fneur.2020.588290","article-title":"Trauma-Related Guillain\u2013Barr\u00e9 Syndrome: Systematic Review of an Emerging Concept","volume":"11","author":"Huang","year":"2020","journal-title":"Front Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1023\/A:1008389607293","article-title":"Guillain-Barr\u00e9 syndrome in a patient with non-Hodgkin's lymphoma","volume":"11","author":"Re","year":"2000","journal-title":"Annals of oncology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/CJI.0000000000000364","article-title":"Immune checkpoint inhibitor\u2013related Guillain-Barr\u00e9 syndrome: a case series and review of the literature","volume":"44","author":"Janssen","year":"2021","journal-title":"J Immunother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/neurolint13010010","article-title":"Rabab'h O, Shah J, Gharaibeh A. Acute and post-acute neurological complications of COVID-19","volume":"13","author":"Al-Ramadan","year":"2021","journal-title":"Neurol Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.7759\/cureus.18360","article-title":"Impact of acute confusional state in patients with COVID-19 and a predictive score","volume":"13","author":"Gogia","year":"2021","journal-title":"Cureus"},{"key":"B19","unstructured":"Neuromuscular complications of COVID 19: a review of literature17080\n            ValaparlaVL\n            JacobSM\n            KomaragiriA\n            PatelAV\n            PatelC\n          Asian J Res Rep Neurol.62023"},{"key":"B20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"The Lancet Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","article-title":"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection","volume":"27","author":"Patone","year":"2021","journal-title":"Nat Med."},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1186\/s41983-021-00310-7","article-title":"Guillain-Barre syndrome in 220 patients with COVID-19","volume-title":"The Egyptian J Neurol Psychiatr Neurosurg.","author":"Finsterer","year":""},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2035","DOI":"10.1212\/WNL.0000000000207900","article-title":"Association between Guillain-Barr\u00e9 syndrome and COVID-19 infection and vaccination: a population-based nested case-control study","volume":"101","author":"Bishara","year":"2023","journal-title":"Neurology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/jns.12419","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: a systematic review and individual participant data meta-analysis","volume":"25","author":"Hasan","year":"2020","journal-title":"J Periph Nerv Syst."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.26355\/eurrev_202303_31588","article-title":"Incidence of Guillain-Barr\u00e9 Syndrome post COVID-19: a systematic review of case reports and case series","volume":"27","author":"Mahmoud","year":"2023","journal-title":"Eur Rev Med Pharm Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1093\/brain\/awab279","article-title":"Guillain-Barr\u00e9 syndrome after SARS-CoV-2 infection in an international prospective cohort study","volume":"144","author":"Luijten","year":"2021","journal-title":"Brain."},{"key":"B27","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/brain\/awaa433","article-title":"Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome","volume":"144","author":"Keddie","year":"2021","journal-title":"Brain."},{"key":"B28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barr\u00e9 syndrome following vaccination in the national influenza immunization program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0140-6736(12)62189-8","article-title":"Association between Guillain-Barr\u00e9 syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis","volume":"381","author":"Salmon","year":"2013","journal-title":"Lancet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"578","DOI":"10.7759\/cureus.37578","article-title":"Guillain-Barr\u00e9 syndrome induced by vaccination against COVID-19: a systematic review and meta-analysis","volume":"15","author":"Ogunjimi","year":"2023","journal-title":"Cureus"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.53845","article-title":"Reports of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the united states","author":"Abara","year":"2023","journal-title":"JAMA Network Open"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00415-024-12186-7","article-title":"Guillain-Barr\u00e9 syndrome and COVID-19 vaccination: a systematic review and meta-analysis","volume":"271","author":"Censi","year":"2024","journal-title":"J Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41541-021-00356-x","article-title":"Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic","volume":"6","author":"Mendon\u00e7a","year":"2021","journal-title":"NPJ Vaccines."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2045853","DOI":"10.1080\/21645515.2022.2045853","article-title":"COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges","volume":"18","author":"Dhama","year":"2022","journal-title":"Hum Vaccin Immunother."},{"key":"B35","unstructured":"R&D Blue Print. World Health Organization.2023"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S2213-2600(23)00349-1","article-title":"Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"11","author":"Zhu","year":"2023","journal-title":"Lancet Respir Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's Palsy in Switzerland","author":"Mutsch","year":"2004","journal-title":"N Engl J Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/mus.27024","article-title":"COVID-19\u2013associated Guillain-Barr\u00e9 syndrome: the early pandemic experience","volume":"62","author":"Caress","year":"2020","journal-title":"Muscle Nerve."},{"key":"B39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jocn.2020.11.013","article-title":"Guillain\u2013Barr\u00e9 syndrome as a parainfectious manifestation of SARS-CoV-2 infection: a case series","volume":"83","author":"Abolmaali","year":"2021","journal-title":"J Clin Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1258579","DOI":"10.3389\/fimmu.2023.1258579","article-title":"Case Report: Four cases of SARS-CoV-2-associated Guillain-Barr\u00e9 Syndrome with SARS-CoV-2-positive cerebrospinal fluid detected by metagenomic next-generation sequencing: a retrospective case series from China","volume":"14","author":"Guan","year":"2023","journal-title":"Front Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10072-023-07279-6","article-title":"COVID-19-associated serum and cerebrospinal fluid cytokines in post-versus para-infectious SARS-CoV-2-related Guillain\u2013Barr\u00e9 syndrome","volume":"3","author":"Massa","year":"2024","journal-title":"Neurol Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40001-023-01055-0","article-title":"Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barr\u00e9 syndrome?","volume":"28","author":"Zheng","year":"2023","journal-title":"Eur J Med Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1017\/cjn.2021.102","article-title":"Guillain Barre syndrome as a complication of COVID-19: a systematic review","volume":"49","author":"Aladawi","year":"2022","journal-title":"Can J Neurol Sci."},{"key":"B44","first-page":"194","article-title":"Guillain-Barr\u00e9 syndrome in patients dying with COVID-19 in Italy: a retrospective study: Guillain-Barr\u00e9 syndrome in 4 COVID-19 deads","volume":"59","author":"Colaizzo","year":"2023","journal-title":"Annali dell'Istituto Superiore di Sanit\u00e0."},{"key":"B45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s41983-023-00633-7","article-title":"Clinical characteristics of Guillain-Barre syndrome in COVID-19: a systematic review and meta-analysis of observational studies","volume":"59","author":"Yusari","year":"2023","journal-title":"Egypt J Neurol Psychiatr Neurosurg."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1078197","DOI":"10.3389\/fimmu.2023.1078197","article-title":"Guillain-Barre syndrome following COVID-19 vaccines: A review of literature","volume":"14","author":"Yu","year":"2023","journal-title":"Front Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","article-title":"Th1\/Th2\/Th17\/Treg cytokines in Guillain\u2013Barr\u00e9 syndrome and experimental autoimmune neuritis","volume":"24","author":"Zhang","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-11-63","article-title":"Interleukin-17 impedes Schwann cell-mediated myelination","volume":"11","author":"Stettner","year":"2014","journal-title":"J Neuroinflammation."},{"key":"B49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","article-title":"Nervous system involvement after infection with COVID-19 and other coronaviruses","volume":"87","author":"Wu","year":"2020","journal-title":"Brain Behav Immun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"102681","DOI":"10.1016\/j.autrev.2020.102681","article-title":"Guillain Barr\u00e9 syndrome and COVID-19: possible role of the cytokine storm","volume":"19","author":"Hussain","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1474-4422(18)30114-5","article-title":"Safety and efficacy of eculizumab in Guillain-Barr\u00e9 syndrome: a multicentre, double-blind, randomised phase 2 trial","volume":"17","author":"Misawa","year":"2018","journal-title":"The Lancet Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1097\/INF.0000000000003146","article-title":"First report of SARS-CoV-2 detection in cerebrospinal fluid in a child with Guillain-Barr\u00e9 syndrome","volume":"40","author":"Ara\u00fajo","year":"2021","journal-title":"Pediatr Infect Dis J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1002\/jmv.27159","article-title":"COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?","volume":"93","author":"Khan","year":"2021","journal-title":"J Med Virol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1136\/jnnp-2020-324279","article-title":"Antiganglioside antibodies in Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection","volume":"91","author":"Civardi","year":"2020","journal-title":"J Neurol Neurosurg Psychiatr."},{"key":"B55","doi-asserted-by":"publisher","first-page":"613628","DOI":"10.3389\/fnagi.2020.613628","article-title":"The neuroimmunology of Guillain-Barr\u00e9 syndrome and the potential role of an aging immune system","volume":"12","author":"Hagen","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"109183","DOI":"10.1016\/j.intimp.2022.109183","article-title":"Molecular mimicry, hyperactive immune system, and SARS-CoV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection","volume":"22","author":"Vahabi","year":"2022","journal-title":"Int Immunopharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"155873","DOI":"10.1016\/j.cyto.2022.155873","article-title":"SARS-CoV-2 triggering autoimmune diseases","volume":"154","author":"Mobasheri","year":"2022","journal-title":"Cytokine."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1396642\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T10:03:34Z","timestamp":1721383414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1396642\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":57,"alternative-id":["10.3389\/fneur.2024.1396642"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1396642","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,5]]},"article-number":"1396642"}}